Avalo Therapeutics, INC. (AVTX) — 10-K Filings

All 10-K filings from Avalo Therapeutics, INC.. Browse 2 Annual Report reports with AI-powered summaries and risk analysis.

10-K Filings (2)

Avalo Therapeutics Files 2024 10-K — Mar 20, 2025 Risk: medium
Avalo Therapeutics, Inc. filed its 2024 10-K on March 20, 2025, reporting on its fiscal year ending December 31, 2024. The company, formerly known as Cerecor In
Avalo Therapeutics, Inc. Files 2023 Annual Report on Form 10-K — Mar 29, 2024 Risk: medium
Avalo Therapeutics, Inc. (AVTX) filed a Annual Report (10-K) with the SEC on March 29, 2024. Avalo Therapeutics, Inc. filed its annual report on Form 10-K for t

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX